<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01285791</url>
  </required_header>
  <id_info>
    <org_study_id>obesity17-HMO-CTIL</org_study_id>
    <nct_id>NCT01285791</nct_id>
  </id_info>
  <brief_title>Sonographic Evaluation of Visceral Fat After Bariatric Surgery</brief_title>
  <official_title>Sonographic Evaluation of Visceral and Subcutaneous Fat in Morbidly Obese Patients Before and After 3 Different Types of Bariatric Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Excess visceral fat is a key factor in the development of metabolic syndrome associated with&#xD;
      obesity. After bariatric surgery, patients experience weight loss accompanied by a decrease&#xD;
      in the amount of total body fat. It is unclear how the different surgical procedures vary in&#xD;
      their effect on the visceral and subcutaneous fat change. Ultrasonography (US) is an&#xD;
      effective, efficient method in assessing this metabolically active layer of fat even when&#xD;
      compared with gold standard techniques such as computed tomography and magnetic resonance&#xD;
      imaging. Only a few studies managed to show the actual decrease in the visceral fat layer&#xD;
      after these kinds of surgeries. The aim is to compare by ultrasound evaluation the extent of&#xD;
      fat layers reduction after laparoscopic adjustable gastric banding (LAGB), laparoscopic&#xD;
      sleeve gastrectomy (LSG) and laparoscopic roux-en-y gastric bypass (LRYGB). The hypothesis is&#xD;
      that the sleeve gastrectomy and gastric bypass being not only a restrictive procedure but&#xD;
      also a malabsorptive procedure will have the best results in decreasing the amount of&#xD;
      visceral fat.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      excess visceral fat is a key factor in the development of metabolic syndrome associated with&#xD;
      obesity. After bariatric surgery, patients experience weight loss accompanied by a decrease&#xD;
      in the amount of total body fat. It is unclear how the different surgical procedures vary in&#xD;
      their effect in reducing the amount of the visceral fat layer . Ultrasonography (US) is an&#xD;
      effective, efficient method in assessing this metabolically active layer of fat even when&#xD;
      compared with gold standard techniques such as computed tomography and magnetic resonance&#xD;
      imaging. Only a few studies managed to show the actual decrease in the visceral fat layer&#xD;
      after these kinds of bariatric surgeries. The aim is to compare by ultrasound evaluation the&#xD;
      extent of fat layers reduction after laparoscopic adjustable gastric banding (LAGB),&#xD;
      laparoscopic sleeve gastrectomy (LSG) and laparoscopic roux-en-y gastric bypass (LRYGB).&#xD;
&#xD;
      Visceral fat (VF) will be defined as the depth, in centimeters, from the rectus abdominis&#xD;
      muscle to the aorta; and subcutaneous fat (SCF) defined as the depth, in centimeters, from&#xD;
      the skin to the rectus abdominis muscle. Results will be compared with anthropometric&#xD;
      measures as weight and waist circumference as well as laboratory results to try and find&#xD;
      correlation between sonographic improvement and anthropometric and laboratory improvement.&#xD;
&#xD;
      The hypothesis is that the sleeve gastrectomy and gastric bypass being not only a restrictive&#xD;
      procedure but also a malabsorptive procedure will have the best results in decreasing the&#xD;
      amount of visceral fat.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Decrease in the Visceral Fat Layer Measured by Ultrasound a Day Before and a Year After Surgery.</measure>
    <time_frame>18 months</time_frame>
    <description>morbid obese patients undergoing a type of bariatric surgery either a laparoscopic gastric banding, a laparoscopic sleeve astrectomy or a laparoscopic gastric bypass, in our department will be evaluated by ultrasound 1 day before surgery and one year after surgery to determine the amount of visceral fat layer-by centimeters- that was decreased .</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Glucose and Triglyceride Blood Level</measure>
    <time_frame>18 months</time_frame>
    <description>finding correlation between sonographic outcome using ultrasound, as measured by the decrease in the level of visceral fat-by centimeters, weight loss and blood levels of triglycerides and glucose.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">39</enrollment>
  <condition>Morbid Obesity</condition>
  <arm_group>
    <arm_group_label>patients undergoing laparoscopic adjustable gastric banding</arm_group_label>
    <description>morbid obese patients undergoing laparoscopic adjustable gastric banding will be evaluated by ultrasound before surgery and one year after surgery to determine the amount of visceral fat layer decreased.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>patients undergoing laparoscopic sleeve gastrectomy</arm_group_label>
    <description>morbid obese patients undergoing laparoscopic sleeve gastrectomy will be evaluated by ultrasound before surgery and one year after surgery to determine the amount of visceral fat layer decreased</description>
  </arm_group>
  <arm_group>
    <arm_group_label>patients undergoing laparoscopic gastric bypass</arm_group_label>
    <description>morbid obese patients undergoing laparoscopic gastric bypass will be evaluated by ultrasound before surgery and one year after surgery to determine the amount of visceral fat layer decreased</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Morbid obese patients admitted electively to our surgery ward after receiving detailed&#xD;
        explanation about each type of surgery and after independently choosing to undergo either a&#xD;
        laparoscopic adjustable gastric banding, a sleeve gastrectomy or a gatsric bypass will be&#xD;
        offered to participate in the study.&#xD;
&#xD;
        The patients must meet criteria for being morbid obese as defined as a body mass index&#xD;
        greater than 40 kg/meter*meter or a body mass index greater than 35 with relevant&#xD;
        comorbidities. The patients must meet other inclusion and exclusion criteria as defined&#xD;
        below.&#xD;
&#xD;
        The patients will be offered to participate in the study regardless of their gender or&#xD;
        race.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age above 18 years and below 70 years&#xD;
&#xD;
          -  patients considered to suffer from morbid obesity as defined as a body mass index&#xD;
             above 40 kg/meter*meter or above 35 kg/meter*meter with comorbidities relevant to&#xD;
             obesity such as : diabetes, hypertension, arthralgia, obstructive sleep apnea and&#xD;
             hyperlipidemia and eligible for surgery&#xD;
&#xD;
          -  patients that electively and independently chose to undergo a bariatric surgery in our&#xD;
             surgery ward.&#xD;
&#xD;
          -  patients expressing their desire to participate in the study and after signing&#xD;
             informed consent.&#xD;
&#xD;
          -  patients that underwent a lecture about the pros and cons of the different types of&#xD;
             bariatric surgery performed in our surgery ward:laparoscopic adjustable gastric&#xD;
             banding, a sleeve gastrectomy or a gastric bypass and chose independently the type of&#xD;
             surgery they want to undergo.&#xD;
&#xD;
          -  patients that tried to lose weight in conventional ways such as physical activity and&#xD;
             diets with no success.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients under the age of 18 or above the age 70.&#xD;
&#xD;
          -  patients unable to read, understand, comprehend and sign the informed consent form.&#xD;
&#xD;
          -  patients not meeting the criteria for the definition morbid obesity as defined as a&#xD;
             body mass index above 40 kg/meter*meter or above 35 kg/meter*meter with comorbidities&#xD;
             relevant to obesity such as : diabetes, hypertension, arthralgia, obstructive sleep&#xD;
             apnea and hyperlipidemia.&#xD;
&#xD;
          -  pregnant patients.&#xD;
&#xD;
          -  patients addicted to alcohol or other recreational drugs.&#xD;
&#xD;
          -  patients suffering from a malignant comorbidity.&#xD;
&#xD;
          -  patients suffering for a morbid obesity state because of a endocrine problem such as&#xD;
             hypothyroidism or cushing disease.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ido Mizrahi, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ministry of Health, Israel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hadassah Medical Organization</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Del Genio F, Del Genio G, De Sio I, Marra M, Alfonsi L, Finelli C, Contaldo F, Pasanisi F. Noninvasive evaluation of abdominal fat and liver changes following progressive weight loss in severely obese patients treated with laparoscopic gastric bypass. Obes Surg. 2009 Dec;19(12):1664-71. doi: 10.1007/s11695-009-9891-x.</citation>
    <PMID>19526270</PMID>
  </reference>
  <verification_date>February 2016</verification_date>
  <study_first_submitted>January 10, 2011</study_first_submitted>
  <study_first_submitted_qc>January 27, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2011</study_first_posted>
  <results_first_submitted>February 18, 2016</results_first_submitted>
  <results_first_submitted_qc>February 18, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 16, 2016</results_first_posted>
  <last_update_submitted>February 18, 2016</last_update_submitted>
  <last_update_submitted_qc>February 18, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 16, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hadassah Medical Organization</investigator_affiliation>
    <investigator_full_name>Ido Mizrahi</investigator_full_name>
    <investigator_title>Ido Mizrahi MD</investigator_title>
  </responsible_party>
  <keyword>morbid obesity</keyword>
  <keyword>intra-abdominal visceral fat</keyword>
  <keyword>gastric bypass</keyword>
  <keyword>sleeve gastrectomy</keyword>
  <keyword>gastric banding</keyword>
  <keyword>visceral fat</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>not planning on sharing data</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Patients Undergoing Laparoscopic Adjustable Gastric Banding</title>
          <description>morbid obese patients undergoing laparoscopic adjustable gastric banding will be evaluated by ultrasound before surgery and one year after surgery to determine the amount of visceral fat layer decreased.</description>
        </group>
        <group group_id="P2">
          <title>Patients Undergoing Laparoscopic Sleeve Gastrectomy</title>
          <description>morbid obese patients undergoing laparoscopic sleeve gastrectomy will be evaluated by ultrasound before surgery and one year after surgery to determine the amount of visceral fat layer decreased</description>
        </group>
        <group group_id="P3">
          <title>Patients Undergoing Laparoscopic Gastric Bypass</title>
          <description>morbid obese patients undergoing laparoscopic gastric bypass will be evaluated by ultrasound before surgery and one year after surgery to determine the amount of visceral fat layer decreased</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Patients Undergoing Laparoscopic Adjustable Gastric Banding</title>
          <description>morbid obese patients undergoing laparoscopic adjustable gastric banding will be evaluated by ultrasound before surgery and one year after surgery to determine the amount of visceral fat layer decreased.</description>
        </group>
        <group group_id="B2">
          <title>Patients Undergoing Laparoscopic Sleeve Gastrectomy</title>
          <description>morbid obese patients undergoing laparoscopic sleeve gastrectomy will be evaluated by ultrasound before surgery and one year after surgery to determine the amount of visceral fat layer decreased</description>
        </group>
        <group group_id="B3">
          <title>Patients Undergoing Laparoscopic Gastric Bypass</title>
          <description>morbid obese patients undergoing laparoscopic gastric bypass will be evaluated by ultrasound before surgery and one year after surgery to determine the amount of visceral fat layer decreased</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="11"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="13"/>
            <count group_id="B4" value="39"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38.9" spread="1.6"/>
                    <measurement group_id="B2" value="36.5" spread="3.1"/>
                    <measurement group_id="B3" value="38.7" spread="3"/>
                    <measurement group_id="B4" value="37.9" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Israel</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="13"/>
                    <measurement group_id="B4" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Decrease in the Visceral Fat Layer Measured by Ultrasound a Day Before and a Year After Surgery.</title>
        <description>morbid obese patients undergoing a type of bariatric surgery either a laparoscopic gastric banding, a laparoscopic sleeve astrectomy or a laparoscopic gastric bypass, in our department will be evaluated by ultrasound 1 day before surgery and one year after surgery to determine the amount of visceral fat layer-by centimeters- that was decreased .</description>
        <time_frame>18 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Patients Undergoing Laparoscopic Adjustable Gastric Banding</title>
            <description>morbid obese patients undergoing laparoscopic adjustable gastric banding will be evaluated by ultrasound before surgery and one year after surgery to determine the amount of visceral fat layer decreased.</description>
          </group>
          <group group_id="O2">
            <title>Patients Undergoing Laparoscopic Sleeve Gastrectomy</title>
            <description>morbid obese patients undergoing laparoscopic sleeve gastrectomy will be evaluated by ultrasound before surgery and one year after surgery to determine the amount of visceral fat layer decreased</description>
          </group>
          <group group_id="O3">
            <title>Patients Undergoing Laparoscopic Gastric Bypass</title>
            <description>morbid obese patients undergoing laparoscopic gastric bypass will be evaluated by ultrasound before surgery and one year after surgery to determine the amount of visceral fat layer decreased</description>
          </group>
        </group_list>
        <measure>
          <title>Decrease in the Visceral Fat Layer Measured by Ultrasound a Day Before and a Year After Surgery.</title>
          <description>morbid obese patients undergoing a type of bariatric surgery either a laparoscopic gastric banding, a laparoscopic sleeve astrectomy or a laparoscopic gastric bypass, in our department will be evaluated by ultrasound 1 day before surgery and one year after surgery to determine the amount of visceral fat layer-by centimeters- that was decreased .</description>
          <units>visceral fat reduction in centimeters</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6" spread="0.8"/>
                    <measurement group_id="O2" value="7.1" spread="0.5"/>
                    <measurement group_id="O3" value="5.6" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Glucose and Triglyceride Blood Level</title>
        <description>finding correlation between sonographic outcome using ultrasound, as measured by the decrease in the level of visceral fat-by centimeters, weight loss and blood levels of triglycerides and glucose.</description>
        <time_frame>18 months</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Patients Undergoing Laparoscopic Adjustable Gastric Banding</title>
          <description>morbid obese patients undergoing laparoscopic adjustable gastric banding will be evaluated by ultrasound before surgery and one year after surgery to determine the amount of visceral fat layer decreased.</description>
        </group>
        <group group_id="E2">
          <title>Patients Undergoing Laparoscopic Sleeve Gastrectomy</title>
          <description>morbid obese patients undergoing laparoscopic sleeve gastrectomy will be evaluated by ultrasound before surgery and one year after surgery to determine the amount of visceral fat layer decreased</description>
        </group>
        <group group_id="E3">
          <title>Patients Undergoing Laparoscopic Gastric Bypass</title>
          <description>morbid obese patients undergoing laparoscopic gastric bypass will be evaluated by ultrasound before surgery and one year after surgery to determine the amount of visceral fat layer decreased</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Ido Mizrahi</name_or_title>
      <organization>Hadassah Medical Organization</organization>
      <phone>+972-2-5844550</phone>
      <email>idomiz17@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

